AbbVie Presents Positive Phase 3 Data Demonstrating Investigational Elagolix Reduces Heavy Menstrual Bleeding in Women with Uterine Fibroids at 2018 AAGL Global Congress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. APGE
5. USO
6. GOOGL
7. MU
8. HOOD
9. DFTX
10. RGNX

Go back to AbbVie Presents Positive Phase 3 Data Demonstrating Investigational Elagolix Reduces Heavy Menstrual Bleeding in Women with Uterine Fibroids at 2018 AAGL Global Congress
AbbVie (NYSE: ABBV) Delayed: 229.36 +12.87 (5.94%)
Previous Close $216.49    52 Week High $68.12 
Open $221.94    52 Week Low $50.71 
Day High $232.32    P/E 49.75 
Day Low $221.94    EPS $4.61 
Volume 6,321,273       

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) Delayed: 160.74 +2.45 (1.55%)
Previous Close $158.29    52 Week High $58.46 
Open $161.17    52 Week Low $31.25 
Day High $161.39    P/E N/A 
Day Low $159.32    EPS $-0.69 
Volume 551,199